연구성과로 돌아가기

2021 연구성과별 연구자 정보 (1149 / 2991)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
IMPACT OF HBEAG ON HEPATOCELLULAR CARCINOMA RISK DURING ORAL ANTIVIRAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS B Lampertico, Pietro Lampertico, P 24 Univ Milan, Fdn Irccs Ca Granda Osped Maggiore Policlin, CRC AM & A Migliavacca Ctr Liver Dis, Milan, Italy J-8463-2018 Lampertico, Pietro
IMPACT OF HBEAG ON HEPATOCELLULAR CARCINOMA RISK DURING ORAL ANTIVIRAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS B Dalekos, George N. Dalekos, GN 25 Univ Thessaly, Dept Med & Res, Lab Internal Med, Volos, Greece
IMPACT OF HBEAG ON HEPATOCELLULAR CARCINOMA RISK DURING ORAL ANTIVIRAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS B Idilman, Ramazan Idilman, R 26 Ankara Univ, Sch Med, Gastroenterol, Ankara, Turkey AFL-0461-2022 Idilman, Ramazan
IMPACT OF HBEAG ON HEPATOCELLULAR CARCINOMA RISK DURING ORAL ANTIVIRAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS B Sypsa, Vana Sypsa, V 27 Natl & Kapodistrian Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, Athens, Greece A-5082-2008 SYPSA, VANA
IMPACT OF HBEAG ON HEPATOCELLULAR CARCINOMA RISK DURING ORAL ANTIVIRAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS B Berg, Thomas Berg, T 28 Univ Leipzig, Med Ctr, Div Hepatol, Dept Med 2, Leipzig, Germany
IMPACT OF HBEAG ON HEPATOCELLULAR CARCINOMA RISK DURING ORAL ANTIVIRAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS B Buti, Maria Buti, M 29 Hosp Univ Vall Dhebron, Dept Internal Med, Liver Unit, Barcelona, Spain A-5327-2019 Buti, MARIA
IMPACT OF HBEAG ON HEPATOCELLULAR CARCINOMA RISK DURING ORAL ANTIVIRAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS B Luis Calleja, Jose Calleja, JL 30 Hosp Univ Puerta Hierro, Idiphim Ciberehd, Majadahonda, Spain A-5351-2010 Panero, Jose
IMPACT OF HBEAG ON HEPATOCELLULAR CARCINOMA RISK DURING ORAL ANTIVIRAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS B Goulis, John Goulis, J 31 Aristotle Univ Thessaloniki, Sch Med, Thessaloniki, Greece
IMPACT OF HBEAG ON HEPATOCELLULAR CARCINOMA RISK DURING ORAL ANTIVIRAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS B Manolakopoulos, Spilios Manolakopoulos, S 32 Natl & Kapodistrian Univ Athens, Sch Med, Gen Hosp Athens Laiko, Dept Gastroenterol, Athens, Greece
IMPACT OF HBEAG ON HEPATOCELLULAR CARCINOMA RISK DURING ORAL ANTIVIRAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS B Janssen, Harry L. A. Janssen, HLA 33 Toronto Gen Hosp, Res Inst, Univ Hlth Network, Toronto Ctr Liver Dis, Toronto, ON, Canada
IMPACT OF HBEAG ON HEPATOCELLULAR CARCINOMA RISK DURING ORAL ANTIVIRAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS B Papatheodoridis, George Papatheodoridis, G 34 Natl & Kapodistrian Univ Athens, Sch Med, Gen Hosp Athens Laiko, Dept Gastroenterol, Athens, Greece A-4603-2008 Papatheodoridis, George
IMPACT OF HBEAG ON HEPATOCELLULAR CARCINOMA RISK DURING ORAL ANTIVIRAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS B Lee, Jeong-Hoon Lee, JH 35 Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea Q-1055-2018 Lee, Jeong-Hoon
IMPACT OF HBEAG ON HEPATOCELLULAR CARCINOMA RISK DURING ORAL ANTIVIRAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS B Lee, Jeong-Hoon Lee, JH 35 Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea Q-1055-2018 Lee, Jeong-Hoon
Impact of immune checkpoint gene CD155 Ala67Thr and CD226 Gly307Ser polymorphisms on small cell lung cancer clinical outcome Lee, Jang Hyuck Lee, JH 1 Kyungpook Natl Univ, Sch Med, Dept Biochem & Cell Biol, Daegu 41944, South Korea yooss@knu.ac.kr;jaeyong@knu.ac.kr;
Impact of immune checkpoint gene CD155 Ala67Thr and CD226 Gly307Ser polymorphisms on small cell lung cancer clinical outcome Lee, Jang Hyuck Lee, JH 1 Kyungpook Natl Univ, Dept Biomed Sci, Plus KNU Biomed Convergence Program BK21, Daegu 41944, South Korea yooss@knu.ac.kr;jaeyong@knu.ac.kr;
페이지 이동: